Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
69 | 27709 | 47.2 | 89% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
172 | 54487 | CELL & TISSUE ENGINEERING//MESENCHYMAL STEM CELLS//ENDOTHELIAL PROGENITOR CELLS |
Classes in level below (level 1) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | CELL & TISSUE ENGINEERING | WoS category | 1395 | 24% | 19% | 5176 |
2 | MESENCHYMAL STEM CELLS | Author keyword | 1116 | 35% | 9% | 2598 |
3 | PLURIPOTENCY | Author keyword | 574 | 61% | 2% | 602 |
4 | EMBRYONIC STEM CELLS | Author keyword | 544 | 39% | 4% | 1086 |
5 | INDUCED PLURIPOTENT STEM CELLS | Author keyword | 509 | 59% | 2% | 577 |
6 | STEM CELLS AND DEVELOPMENT | Journal | 485 | 43% | 3% | 859 |
7 | HUMAN EMBRYONIC STEM CELLS | Author keyword | 458 | 57% | 2% | 548 |
8 | STEM CELLS | Author keyword | 405 | 19% | 7% | 1898 |
9 | REPROGRAMMING | Author keyword | 338 | 50% | 2% | 494 |
10 | CELL THERAPY | Author keyword | 329 | 35% | 3% | 770 |
Web of Science journal categories |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | Cell & Tissue Engineering | 1395 | 24% | 19% | 5176 |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MESENCHYMAL STEM CELLS | 1116 | 35% | 9% | 2598 | Search MESENCHYMAL+STEM+CELLS | Search MESENCHYMAL+STEM+CELLS |
2 | PLURIPOTENCY | 574 | 61% | 2% | 602 | Search PLURIPOTENCY | Search PLURIPOTENCY |
3 | EMBRYONIC STEM CELLS | 544 | 39% | 4% | 1086 | Search EMBRYONIC+STEM+CELLS | Search EMBRYONIC+STEM+CELLS |
4 | INDUCED PLURIPOTENT STEM CELLS | 509 | 59% | 2% | 577 | Search INDUCED+PLURIPOTENT+STEM+CELLS | Search INDUCED+PLURIPOTENT+STEM+CELLS |
5 | HUMAN EMBRYONIC STEM CELLS | 458 | 57% | 2% | 548 | Search HUMAN+EMBRYONIC+STEM+CELLS | Search HUMAN+EMBRYONIC+STEM+CELLS |
6 | STEM CELLS | 405 | 19% | 7% | 1898 | Search STEM+CELLS | Search STEM+CELLS |
7 | REPROGRAMMING | 338 | 50% | 2% | 494 | Search REPROGRAMMING | Search REPROGRAMMING |
8 | CELL THERAPY | 329 | 35% | 3% | 770 | Search CELL+THERAPY | Search CELL+THERAPY |
9 | MESENCHYMAL STROMAL CELLS | 325 | 54% | 2% | 418 | Search MESENCHYMAL+STROMAL+CELLS | Search MESENCHYMAL+STROMAL+CELLS |
10 | ADIPOSE DERIVED STEM CELLS | 193 | 51% | 1% | 269 | Search ADIPOSE+DERIVED+STEM+CELLS | Search ADIPOSE+DERIVED+STEM+CELLS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DEFINED FACTORS | 1219 | 67% | 4% | 1108 |
2 | STROMAL CELLS | 1143 | 29% | 12% | 3399 |
3 | ES CELLS | 944 | 56% | 4% | 1144 |
4 | HUMAN BLASTOCYSTS | 829 | 62% | 3% | 865 |
5 | HUMAN SOMATIC CELLS | 796 | 63% | 3% | 810 |
6 | PLURIPOTENCY | 699 | 48% | 4% | 1072 |
7 | PROGENITOR CELLS | 665 | 16% | 14% | 3802 |
8 | IPS CELLS | 596 | 73% | 2% | 455 |
9 | MARROW STROMAL CELLS | 584 | 27% | 7% | 1866 |
10 | SKELETAL MYOBLAST TRANSPLANTATION | 527 | 79% | 1% | 333 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STEM CELLS AND DEVELOPMENT | 485 | 43% | 3% | 859 |
2 | STEM CELLS | 334 | 27% | 4% | 1060 |
3 | CYTOTHERAPY | 154 | 30% | 2% | 432 |
4 | STEM CELL RESEARCH & THERAPY | 136 | 43% | 1% | 241 |
5 | STEM CELL REVIEWS AND REPORTS | 131 | 44% | 1% | 226 |
6 | STEM CELLS INTERNATIONAL | 98 | 41% | 1% | 185 |
7 | CELL TRANSPLANTATION | 94 | 19% | 2% | 453 |
8 | STEM CELLS TRANSLATIONAL MEDICINE | 94 | 40% | 1% | 187 |
9 | STEM CELL RESEARCH | 89 | 37% | 1% | 191 |
10 | CELL STEM CELL | 81 | 29% | 1% | 240 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
The promise of induced pluripotent stem cells in research and therapy | 2012 | 290 | 90 | 93% |
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications | 2015 | 6 | 98 | 84% |
Use of Mesenchymal Stem Cells for Therapy of Cardiac Disease | 2015 | 6 | 162 | 73% |
Caveats of mesenchymal stem cell therapy in solid organ transplantation | 2015 | 5 | 64 | 80% |
Mesenchymal stem cells in health and disease | 2008 | 918 | 113 | 78% |
iPS cells: a game changer for future medicine | 2014 | 45 | 56 | 70% |
Induced Pluripotent Stem Cells: Past, Present, and Future | 2012 | 162 | 79 | 86% |
Concise Review: The Surface Markers and Identity of Human Mesenchymal Stem Cells | 2014 | 37 | 111 | 69% |
Cell Therapy for Heart Failure A Comprehensive Overview of Experimental and Clinical Studies, Current Challenges, and Future Directions | 2013 | 79 | 210 | 84% |
Immunobiology of mesenchymal stem cells | 2014 | 35 | 143 | 71% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | STEM CELL | 249 | 25% | 3.1% | 852 |
2 | STEM CELL BIOL | 93 | 23% | 1.3% | 363 |
3 | REGENERAT MED | 74 | 14% | 1.8% | 494 |
4 | YAMANAKA IPS CELL SPECIAL PROJECT | 73 | 96% | 0.1% | 23 |
5 | PLURIPOTENT CELL STUDIES | 52 | 74% | 0.1% | 39 |
6 | PPRF | 42 | 83% | 0.1% | 24 |
7 | RIC E MENNI | 42 | 72% | 0.1% | 33 |
8 | EXCELLENCE TISSUE ENGN | 41 | 55% | 0.2% | 51 |
9 | CHA STEM CELL | 35 | 38% | 0.3% | 75 |
10 | STEM CELL BIOL REGENERAT MED | 35 | 17% | 0.7% | 188 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000015825 | ENDOTHELIAL PROGENITOR CELLS//ENDOTHELIAL PROGENITOR CELL//ARTERIOGENESIS |
2 | 0.0000014747 | EMBRYONAL CARCINOMA//TERATOCARCINOMA//HNT |
3 | 0.0000012955 | CANCER STEM CELLS//CD133//ADULT NEUROGENESIS |
4 | 0.0000008795 | SPINAL CORD INJURIES//OLFACTORY ENSHEATHING CELLS//NOGO A |
5 | 0.0000008781 | CARDIAC TISSUE ENGINEERING//TISSUE ENGINEERING//ADV BIOMED ENGN SCI |
6 | 0.0000008752 | BIOARTIFICIAL LIVER//LIVER REGENERATION//HEPATOCYTE TRANSPLANTATION |
7 | 0.0000007189 | ETS 1//PU1//HEMANGIOBLAST |
8 | 0.0000006202 | XIST//X CHROMOSOME INACTIVATION//TSIX |
9 | 0.0000006089 | FIBROBLAST GROWTH FACTOR//KERATINOCYTE GROWTH FACTOR//SPROUTY |
10 | 0.0000005702 | NUR77//NURR1//TR4 |